FLOW - ETF AI Analysis

Top Page

Global X U.S. Cash Flow Kings 100 ETF (FLOW)

Rating:69Neutral

Price Target:―

The Global X U.S. Cash Flow Kings 100 ETF (FLOW) has a solid overall rating, reflecting a mix of strong and moderate-performing holdings. Top contributors like Accenture and Cognizant drive the fund's rating with their robust financial performance, strategic focus on AI, and positive earnings call insights. However, weaker holdings such as Pfizer and Bristol-Myers Squibb, which face challenges like declining revenue and high debt levels, slightly weigh down the fund's overall score. A key risk factor is the ETF's exposure to companies with sector-specific vulnerabilities, such as healthcare and energy, which may impact stability during market fluctuations.

Positive Factors

Strong Performing Holdings

Several top holdings, such as Archer Daniels Midland and Altria Group, have delivered strong year-to-date gains, supporting the ETF’s overall performance.

Sector Diversification

The ETF is spread across multiple sectors, including Technology, Consumer Cyclical, and Energy, which helps reduce reliance on any single industry.

Low Expense Ratio

The fund’s expense ratio of 0.25% is relatively low, making it cost-effective for investors.

Negative Factors

Underperforming Holdings

Several top holdings, such as Accenture, Pfizer, and Diamondback, have lagged in year-to-date performance, which could weigh on future returns.

High U.S. Concentration

With nearly 99% of its geographic exposure in the U.S., the ETF lacks diversification across global markets.

Sector Overweight Risk

The fund has significant exposure to Technology, Consumer Cyclical, and Energy sectors, which could make it vulnerable to downturns in these industries.

FLOW vs. SPDR S&P 500 ETF (SPY)

AUM25.08M

RegionNorth America

Expense Ratio0.25%

Beta0.81

IssuerGlobal X

Inception DateJul 10, 2023

Dividend Yield2.08%

Asset ClassEquity

Index TrackedGlobal X U.S. Cash Flow Kings 100 Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume984

30 Day Avg. Volume1,925

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

40.16

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering99

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

FLOW Summary

The Global X U.S. Cash Flow Kings 100 ETF (ticker: FLOW) is designed to invest in 100 U.S. companies that excel at generating strong cash flow, a sign of financial health and efficiency. It includes well-known companies like Pfizer and Archer Daniels Midland, spanning sectors such as technology, energy, and healthcare. This ETF is ideal for investors seeking diversification across high-quality U.S. firms with stable financial foundations. However, since it focuses heavily on U.S. companies, its performance can be impacted by changes in the U.S. economy or market conditions.

How much will it cost me?The Global X U.S. Cash Flow Kings 100 ETF (FLOW) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This is lower than average for actively managed ETFs, as it focuses on a specific strategy targeting companies with strong cash flow metrics while keeping costs relatively affordable.

What would affect this ETF?The Global X U.S. Cash Flow Kings 100 ETF (FLOW) could benefit from strong economic growth in the U.S., particularly in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns could negatively impact cash flow generation for companies in these sectors, while regulatory changes in industries like healthcare or energy might also pose risks. The ETF’s focus on financially resilient companies may help mitigate some of these challenges over time.

FLOW Top 10 Holdings

The Global X U.S. Cash Flow Kings 100 ETF leans heavily into U.S. companies with strong cash flow generation, with notable exposure to technology and energy sectors. Rising names like Fox and Warner Bros are helping lift the fund, driven by strategic initiatives and solid performance in media and streaming. However, healthcare giants like Pfizer and Bristol-Myers Squibb are lagging, weighed down by revenue challenges and bearish momentum. Energy stocks like Halliburton and Diamondback show mixed results, reflecting oil price volatility. Overall, the fund’s sector concentration adds a dynamic but somewhat uneven performance story.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
WBD	Warner Bros	2.89%	$741.05K	$73.09B	144.32%	68 Neutral
CTSH	Cognizant	2.36%	$604.01K	$40.46B	4.85%	79 Outperform
OMC	Omnicom Group	2.30%	$589.24K	$25.31B	-11.15%	73 Outperform
HAL	Halliburton	2.29%	$587.64K	$24.51B	-0.21%	72 Outperform
DLTR	Dollar Tree	2.27%	$582.79K	$25.84B	85.29%	61 Neutral
FOXA	Fox	2.24%	$575.13K	$29.91B	51.02%	77 Outperform
SLB	Schlumberger	2.22%	$568.75K	$60.26B	-1.91%	75 Outperform
BMY	Bristol-Myers Squibb	2.15%	$552.09K	$104.23B	-6.04%	78 Outperform
FANG	Diamondback	2.13%	$545.87K	$45.00B	-4.08%	81 Outperform
ACN	Accenture	2.13%	$545.61K	$167.67B	-24.62%	80 Outperform

FLOW Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

34.62

Positive

100DMA

34.10

Positive

200DMA

32.16

Positive

Market Momentum

MACD

0.56

Negative

RSI

69.11

Neutral

STOCH

93.41

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.08, equal to the 50-day MA of 34.62, and equal to the 200-day MA of 32.16, indicating a bullish trend. The MACD of 0.56 indicates Negative momentum. The RSI at 69.11 is Neutral, neither overbought nor oversold. The STOCH value of 93.41 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLOW.

FLOW Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
FLOW	―	―	$25.08M	0.25%	―
RVER	―	―	$99.78M	0.66%	―
TMFE	―	―	$99.38M	0.50%	―
BAMD	―	―	$97.93M	0.89%	―
STNC	―	―	$93.83M	0.85%	―
FFTY	―	―	$87.30M	0.80%	―

Performance Comparison

FLOW

Global X U.S. Cash Flow Kings 100 ETF

36.51

4.52

14.13%

RVER

Trenchless Fund ETF

―

TMFE

Motley Fool Capital Efficiency 100 Index ETF

―

BAMD

Brookstone Dividend Stock ETF

―

STNC

Stance Equity ESG Large Cap Core ETF

―

FFTY

Innovator IBD 50 ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents